|
Market Closed -
Other stock markets
|
After hours 20:00:00 | |||
| 214.73 USD | -0.12% |
|
219.25 | +2.10% |
| 04-10 | TD Cowen Adjusts Price Target on Texas Instruments to $250 From $240, Maintains Buy Rating | MT |
| 04-09 | Texas Instruments Shares Rise After Stifel Upgrade | MT |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | 25.32 | 24.32 | 15.35 | 10.05 | 10.92 | |||||
Return on Total Capital | 29.46 | 27.87 | 17.44 | 11.37 | 12.28 | |||||
Return On Equity % | 69 | 62.69 | 41.37 | 28.4 | 30.15 | |||||
Return on Common Equity | 68.7 | 62.41 | 41.15 | 28.25 | 29.98 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 67.47 | 68.76 | 62.9 | 58.14 | 57.02 | |||||
SG&A Margin | 9.04 | 8.73 | 10.51 | 10.73 | 10.6 | |||||
EBITDA Margin % | 53.51 | 55.02 | 48.46 | 44.52 | 45.49 | |||||
EBITA Margin % | 49.39 | 50.4 | 41.75 | 34.88 | 34.65 | |||||
EBIT Margin % | 48.62 | 50.4 | 41.75 | 34.88 | 34.65 | |||||
Income From Continuing Operations Margin % | 42.35 | 43.68 | 37.16 | 30.68 | 28.28 | |||||
Net Income Margin % | 42.35 | 43.68 | 37.16 | 30.68 | 28.28 | |||||
Net Avail. For Common Margin % | 42.17 | 43.48 | 36.97 | 30.53 | 28.12 | |||||
Normalized Net Income Margin | 30.22 | 31.31 | 26.46 | 21.29 | 20.6 | |||||
Levered Free Cash Flow Margin | 22.49 | 20.28 | -2.8 | -3.31 | -1.7 | |||||
Unlevered Free Cash Flow Margin | 23.11 | 20.95 | -1.54 | -1.28 | 0.22 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.83 | 0.77 | 0.59 | 0.46 | 0.5 | |||||
Fixed Assets Turnover | 3.99 | 3.1 | 1.96 | 1.47 | 1.49 | |||||
Receivables Turnover (Average Receivables) | 11.78 | 11.14 | 9.52 | 8.92 | 9.6 | |||||
Inventory Turnover (Average Inventory) | 3.09 | 2.68 | 1.92 | 1.54 | 1.63 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 5.33 | 4.7 | 4.55 | 4.12 | 4.35 | |||||
Quick Ratio | 4.45 | 3.67 | 3.12 | 2.8 | 2.71 | |||||
Operating Cash Flow to Current Liabilities | 3.41 | 2.92 | 1.93 | 1.73 | 2.26 | |||||
Days Sales Outstanding (Average Receivables) | 30.99 | 32.77 | 38.36 | 41.02 | 38 | |||||
Days Outstanding Inventory (Average Inventory) | 118.19 | 136.12 | 189.69 | 238.32 | 224.1 | |||||
Average Days Payable Outstanding | 32.91 | 36.53 | 38.97 | 41.95 | 36.52 | |||||
Cash Conversion Cycle (Average Days) | 116.27 | 132.36 | 189.08 | 237.38 | 225.58 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 61.55 | 62.8 | 69.77 | 85.06 | 90.82 | |||||
Total Debt / Total Capital | 38.1 | 38.57 | 41.1 | 45.96 | 47.59 | |||||
LT Debt/Equity | 57.18 | 58.85 | 65.7 | 79.92 | 87.02 | |||||
Long-Term Debt / Total Capital | 35.4 | 36.15 | 38.7 | 43.19 | 45.6 | |||||
Total Liabilities / Total Assets | 45.97 | 46.42 | 47.76 | 52.4 | 52.95 | |||||
EBIT / Interest Expense | 48.47 | 47.17 | 20.72 | 10.74 | 11.28 | |||||
EBITDA / Interest Expense | 54.02 | 52.02 | 24.41 | 13.83 | 14.92 | |||||
(EBITDA - Capex) / Interest Expense | 40.64 | 38.95 | 10.05 | 4.35 | 6.55 | |||||
Total Debt / EBITDA | 0.83 | 0.82 | 1.37 | 2.05 | 1.82 | |||||
Net Debt / EBITDA | -0.15 | 0.01 | 0.37 | 0.97 | 1.22 | |||||
Total Debt / (EBITDA - Capex) | 1.1 | 1.1 | 3.32 | 6.51 | 4.16 | |||||
Net Debt / (EBITDA - Capex) | -0.21 | 0.01 | 0.91 | 3.08 | 2.79 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 26.85 | 9.18 | -12.53 | -10.72 | 13.05 | |||||
Gross Profit, 1 Yr. Growth % | 33.52 | 11.27 | -19.98 | -17.47 | 10.88 | |||||
EBITDA, 1 Yr. Growth % | 43.16 | 12.28 | -24.71 | -18.88 | 17.29 | |||||
EBITA, 1 Yr. Growth % | 47.97 | 11.42 | -29.34 | -26.37 | 14.5 | |||||
EBIT, 1 Yr. Growth % | 50.51 | 13.2 | -29.34 | -26.37 | 14.5 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 38.86 | 12.61 | -25.59 | -26.28 | 4.21 | |||||
Net Income, 1 Yr. Growth % | 38.86 | 12.61 | -25.59 | -26.28 | 4.21 | |||||
Normalized Net Income, 1 Yr. Growth % | 46.81 | 13.11 | -27.9 | -28.16 | 9.34 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 38.36 | 13.87 | -24.83 | -26.46 | 4.81 | |||||
Accounts Receivable, 1 Yr. Growth % | 20.3 | 11.4 | -5.7 | -3.81 | 14.19 | |||||
Inventory, 1 Yr. Growth % | -2.3 | 44.35 | 45.05 | 13.2 | 6.12 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 56.24 | 30.34 | 44.77 | 13.48 | 8.57 | |||||
Total Assets, 1 Yr. Growth % | 27.52 | 10.26 | 18.9 | 9.77 | -2.6 | |||||
Tangible Book Value, 1 Yr. Growth % | 88.94 | 13.25 | 22.35 | -0.23 | -4.71 | |||||
Common Equity, 1 Yr. Growth % | 45.13 | 9.33 | 15.92 | 0.04 | -3.73 | |||||
Cash From Operations, 1 Yr. Growth % | 42.63 | -0.41 | -26.38 | -1.59 | 13.22 | |||||
Capital Expenditures, 1 Yr. Growth % | 279.35 | 13.61 | 81.3 | -4.95 | -5.6 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | 1.29 | -1.53 | -111.6 | 20.24 | -48.5 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | 1.16 | -1.05 | -106.18 | -4.65 | -114.55 | |||||
Dividend Per Share, 1 Yr. Growth % | 13.17 | 11.4 | 7.04 | 4.78 | 4.56 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 12.93 | 17.68 | -2.27 | -11.63 | 0.46 | |||||
Gross Profit, 2 Yr. CAGR % | 16.21 | 21.89 | -5.64 | -18.74 | -4.34 | |||||
EBITDA, 2 Yr. CAGR % | 21.23 | 28.65 | -7.48 | -21.88 | -2.66 | |||||
EBITA, 2 Yr. CAGR % | 23.19 | 30.53 | -10.66 | -27.87 | -8.49 | |||||
EBIT, 2 Yr. CAGR % | 25.28 | 30.53 | -9.96 | -27.87 | -8.49 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 24.44 | 25.05 | -8.46 | -25.94 | -12.35 | |||||
Net Income, 2 Yr. CAGR % | 24.44 | 25.05 | -8.46 | -25.94 | -12.35 | |||||
Normalized Net Income, 2 Yr. CAGR % | 24.83 | 28.87 | -9.08 | -28.03 | -11.37 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 25.58 | 25.52 | -7.48 | -25.65 | -12.21 | |||||
Accounts Receivable, 2 Yr. CAGR % | 25.85 | 15.77 | 2.5 | -4.76 | 4.81 | |||||
Inventory, 2 Yr. CAGR % | -2.3 | 18.75 | 44.7 | 28.14 | 9.6 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 24.1 | 42.71 | 37.36 | 24.62 | 11 | |||||
Total Assets, 2 Yr. CAGR % | 17.03 | 18.57 | 14.49 | 14.24 | 3.4 | |||||
Tangible Book Value, 2 Yr. CAGR % | 46.58 | 46.28 | 17.71 | 10.49 | -2.5 | |||||
Common Equity, 2 Yr. CAGR % | 22.35 | 25.96 | 12.57 | 7.68 | -1.86 | |||||
Cash From Operations, 2 Yr. CAGR % | 14.76 | 19.18 | -14.37 | -14.88 | 5.55 | |||||
Capital Expenditures, 2 Yr. CAGR % | 70.49 | 107.6 | 43.52 | 31.27 | -5.28 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -0.66 | -0.13 | -65.81 | -65.34 | -21.65 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -0.54 | 0.05 | -75 | -78.78 | -62.05 | |||||
Dividend Per Share, 2 Yr. CAGR % | 14.52 | 12.28 | 9.2 | 5.9 | 4.67 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 5.14 | 11.67 | 6.6 | -5.17 | -4.07 | |||||
Gross Profit, 3 Yr. CAGR % | 6.39 | 14.54 | 5.93 | -9.76 | -9.87 | |||||
EBITDA, 3 Yr. CAGR % | 8.94 | 18.17 | 8.44 | -11.12 | -11 | |||||
EBITA, 3 Yr. CAGR % | 8.97 | 19.14 | 7.28 | -15.87 | -16.41 | |||||
EBIT, 3 Yr. CAGR % | 10.09 | 21.12 | 7.28 | -15.44 | -16.41 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 11.66 | 20.37 | 5.18 | -14.83 | -17.01 | |||||
Net Income, 3 Yr. CAGR % | 11.66 | 20.37 | 5.18 | -14.83 | -17.01 | |||||
Normalized Net Income, 3 Yr. CAGR % | 9.86 | 20.79 | 7.08 | -15.94 | -17.26 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 13.87 | 21.55 | 5.8 | -14.29 | -16.63 | |||||
Accounts Receivable, 3 Yr. CAGR % | 12.12 | 20.84 | 8.12 | 0.35 | 1.18 | |||||
Inventory, 3 Yr. CAGR % | -4.85 | 11.27 | 26.94 | 33.33 | 20.33 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 20.76 | 26.15 | 43.39 | 26.5 | 19.02 | |||||
Total Assets, 3 Yr. CAGR % | 12.92 | 14.72 | 18.68 | 12.9 | 8.33 | |||||
Tangible Book Value, 3 Yr. CAGR % | 31.42 | 34.5 | 37.82 | 11.4 | 5.17 | |||||
Common Equity, 3 Yr. CAGR % | 14.02 | 17.85 | 22.52 | 8.23 | 3.74 | |||||
Cash From Operations, 3 Yr. CAGR % | 6.79 | 9.46 | 1.5 | -10.31 | -6.39 | |||||
Capital Expenditures, 3 Yr. CAGR % | 29.6 | 48.91 | 98.43 | 25.1 | 17.61 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | -3.02 | -0.95 | -50.64 | -50.2 | -58.83 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | -2.69 | -0.71 | -59.96 | -64.05 | -79.41 | |||||
Dividend Per Share, 3 Yr. CAGR % | 16.98 | 13.47 | 10.51 | 7.7 | 5.45 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 6.53 | 6.01 | 2.11 | 1.69 | 4.1 | |||||
Gross Profit, 5 Yr. CAGR % | 8.43 | 7.45 | 1.4 | -0.15 | 1.7 | |||||
EBITDA, 5 Yr. CAGR % | 11.47 | 9.85 | 2.26 | 0.84 | 3.85 | |||||
EBITA, 5 Yr. CAGR % | 12.17 | 9.71 | 0.88 | -1.78 | 0.67 | |||||
EBIT, 5 Yr. CAGR % | 13.26 | 10.84 | 1.82 | -0.81 | 0.67 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 16.66 | 18.9 | 3.13 | -0.88 | -2.22 | |||||
Net Income, 5 Yr. CAGR % | 16.66 | 18.9 | 3.13 | -0.88 | -2.22 | |||||
Normalized Net Income, 5 Yr. CAGR % | 12.53 | 10.49 | 2.09 | -1.31 | -0.72 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | 18.89 | 21.14 | 4.8 | -0.14 | -1.81 | |||||
Accounts Receivable, 5 Yr. CAGR % | 6.07 | 8.2 | 8.16 | 9.86 | 6.78 | |||||
Inventory, 5 Yr. CAGR % | 1.31 | 7.1 | 12.52 | 17.74 | 19.7 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 17.42 | 22.36 | 27.15 | 25.53 | 27.98 | |||||
Total Assets, 5 Yr. CAGR % | 8.47 | 9.05 | 13.55 | 14.53 | 12.31 | |||||
Tangible Book Value, 5 Yr. CAGR % | 13.13 | 15.39 | 25.75 | 24.32 | 20 | |||||
Common Equity, 5 Yr. CAGR % | 4.95 | 7.12 | 13.44 | 13.67 | 12.11 | |||||
Cash From Operations, 5 Yr. CAGR % | 13.67 | 10.21 | -2.24 | -1.02 | 3.1 | |||||
Capital Expenditures, 5 Yr. CAGR % | 35.91 | 32.11 | 35 | 41.59 | 47.62 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | 2.89 | 0.31 | -35.89 | -34.15 | -40.62 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | 3.17 | 0.72 | -43.32 | -45.83 | -60.81 | |||||
Dividend Per Share, 5 Yr. CAGR % | 20.75 | 17.21 | 13.8 | 10.38 | 8.13 |
- Stock Market
- Equities
- TXN Stock
- Financials Texas Instruments Incorporated
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















